CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Executive Officer gave up 457 shares (to pay taxes)
- 4 Shares withheld for taxes SVP and CFO gave up 176 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 164 shares (to pay taxes)
- 4/A Shares withheld for taxes See Remarks gave up 370 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 176 shares (to pay taxes)
- 4 Grant or award See Remarks acquired 1,000 shares (grant or award)
- 4 Open-market sale Director sold 87,500 shares at an average $0.60 ($52,773)
- 4 Open-market sale Director sold 22,698 shares at $0.55 ($12,484)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4/A Open-market sale Director sold 77,302 shares at an average $0.55 ($42,540)
Page 9 of 33 · 648 filings